Literature DB >> 30729513

Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives.

Mitchell S Cairo1, Auke Beishuizen2,3.   

Abstract

The 6th International Symposium on Childhood, Adolescent and Young Adult (CAYA) Non-Hodgkin Lymphoma (NHL) was held in Rotterdam, Netherlands, 26-29 September, 2018. This summary manuscript is a perspective on the presentations from the plenary scientific sessions, including wellness and survivorship, B-cell NHL, AYA lymphoma, translational NHL biology, lymphoma immunology, bone marrow transplantation and cell therapy, T/Natural Killer cell lymphoma, anaplastic large cell lymphoma, lymphoblastic lymphoma, novel lymphoma therapeutics and Hodgkin lymphoma. The symposium was attended by over 260 registrants from 42 different countries and included young, middle and senior investigators. Finally, the Angelo Rosolen, MD, Memorial Lecture was delivered by Alfred Reiter, MD.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  Childhood; adolescent; current perspectives; non-Hodgkin lymphoma; young adult

Mesh：

Substances：

Year:  2019        PMID： 30729513      PMCID： PMC6897376          DOI： 10.1111/bjh.15764

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  76 in total

1.  Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.

Authors:  S T Balbach; O Makarova; B R Bonn; M Zimmermann; M Rohde; I Oschlies; W Klapper; C Rössig; B Burkhardt
Journal:  Leukemia       Date:  2015-07-28       Impact factor: 11.528

2.  Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation.

Authors:  Janine Schmidt; Joan Enric Ramis-Zaldivar; Ferran Nadeu; Blanca Gonzalez-Farre; Alba Navarro; Caoimhe Egan; Ivonne Aidee Montes-Mojarro; Teresa Marafioti; Jose Cabeçadas; Jon van der Walt; Stefan Dojcinov; Andreas Rosenwald; German Ott; Irina Bonzheim; Falko Fend; Elias Campo; Elaine S Jaffe; Itziar Salaverria; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2017-05-22       Impact factor: 22.113

3.  Revised International Pediatric Non-Hodgkin Lymphoma Staging System.

Authors:  Angelo Rosolen; Sherrie L Perkins; C Ross Pinkerton; R Paul Guillerman; John T Sandlund; Catherine Patte; Alfred Reiter; Mitchell S Cairo
Journal:  J Clin Oncol       Date:  2015-05-04       Impact factor: 44.544

4.  International Pediatric Non-Hodgkin Lymphoma Response Criteria.

Authors:  John T Sandlund; R Paul Guillerman; Sherrie L Perkins; C Ross Pinkerton; Angelo Rosolen; Catherine Patte; Alfred Reiter; Mitchell S Cairo
Journal:  J Clin Oncol       Date:  2015-05-04       Impact factor: 44.544

5.  Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.

Authors:  Yaya Chu; Sanghoon Lee; Tishi Shah; Changhong Yin; Matthew Barth; Rodney R Miles; Janet Ayello; Erin Morris; Lauren Harrison; Carmella Van de Ven; Paul Galardy; Stanton C Goldman; Megan S Lim; Michelle Hermiston; Linda M McAllister-Lucas; Lisa Giulino-Roth; Sherrie L Perkins; Mitchell S Cairo
Journal:  Oncoimmunology       Date:  2018-10-11       Impact factor: 8.110

6.  PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma.

Authors:  Lakshmi Nayak; Fabio M Iwamoto; Ann LaCasce; Srinivasan Mukundan; Margaretha G M Roemer; Bjoern Chapuy; Philippe Armand; Scott J Rodig; Margaret A Shipp
Journal:  Blood       Date:  2017-03-29       Impact factor: 22.113

Review 7.  Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science.

Authors:  Mitchell S Cairo; Ross Pinkerton
Journal:  Br J Haematol       Date:  2016-05-02       Impact factor: 6.998

Review 8.  Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.

Authors:  Lisa Giulino-Roth; Stanton Goldman
Journal:  Br J Haematol       Date:  2016-03-21       Impact factor: 6.998

9.  Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress.

Authors:  Tim I M Malcolm; Patrick Villarese; Camilla J Fairbairn; Laurence Lamant; Amélie Trinquand; C Elizabeth Hook; G A Amos Burke; Laurence Brugières; Katherine Hughes; Dominique Payet; Olaf Merkel; Ana-Iris Schiefer; Ibraheem Ashankyty; Shahid Mian; Mariusz Wasik; Martin Turner; Lukas Kenner; Vahid Asnafi; Elizabeth Macintyre; Suzanne D Turner
Journal:  Nat Commun       Date:  2016-01-12       Impact factor: 14.919

10.  Base-pair resolution DNA methylome of the EBV-positive Endemic Burkitt lymphoma cell line DAUDI determined by SOLiD bisulfite-sequencing.

Authors:  B Kreck; J Richter; O Ammerpohl; M Barann; D Esser; B S Petersen; I Vater; E M Murga Penas; C A Bormann Chung; S Seisenberger; V Lee Boyd; S Smallwood; H G Drexler; R A F Macleod; M Hummel; F Krueger; R Häsler; S Schreiber; P Rosenstiel; A Franke; R Siebert
Journal:  Leukemia       Date:  2013-01-11       Impact factor: 11.528
View more
  8 in total

Review 1.  Surveillance imaging in pediatric lymphoma.

Authors:  Stephan D Voss; Mitchell S Cairo
Journal:  Pediatr Radiol       Date:  2019-10-16

Review 2.  Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective.

Authors:  Irtiza N Sheikh; Amr Elgehiny; Dristhi Ragoonanan; Kris M Mahadeo; Yago Nieto; Sajad Khazal
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

3.  iTRAQ-Based Proteomic Analysis Reveals Potential Serum Biomarkers for Pediatric Non-Hodgkin's Lymphoma.

Authors:  Runhong Yu; Linna Cheng; Shiwei Yang; Yufeng Liu; Zunmin Zhu
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

Review 4.  The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL).

Authors:  Yaya Chu; Margaret Lamb; Mitchell S Cairo; Dean A Lee
Journal:  Curr Treat Options Oncol       Date:  2022-03-08

5.  Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis.

Authors:  Woojung Jeon; Young Kwon Koh; Sunghan Kang; Hyery Kim; Kyung-Nam Koh; Ho Joon Im
Journal:  Blood Res       Date:  2022-03-31

6.  Evaluation and management of systemic corticosteroids-induced ocular hypertension in children with non-Hodgkin lymphoma.

Authors:  Yitian Chang; YuTong Zhang; Zhihua Cui; Xianmei Jin; Yufei Zhao; Lingling Liang; Jian Chang
Journal:  Front Pediatr       Date:  2022-08-12       Impact factor: 3.569

7.  Clinical Characteristics and Treatment Outcomes of Myeloid Sarcoma in Children: The Experience of the Polish Pediatric Leukemia and Lymphoma Study Group.

Authors:  Magdalena Samborska; Małgorzata Barańska; Jacek Wachowiak; Jolanta Skalska-Sadowska; Sheanda Thambyrajah; Małgorzata Czogała; Walentyna Balwierz; Sylwia Kołtan; Katarzyna Peszyńska-Żelazny; Mariusz Wysocki; Tomasz Ociepa; Tomasz Urasiński; Grażyna Wróbel; Jadwiga Węcławek-Tompol; Bogna Ukielska; Alicja Chybicka; Anna Kitszel; Maryna Krawczuk-Rybak; Anna Szmydki-Baran; Iwona Malinowska; Michał Matysiak; Agnieszka Mizia-Malarz; Renata Tomaszewska; Tomasz Szczepański; Agnieszka Chodała-Grzywacz; Grażyna Karolczyk; Lucyna Maciejka-Kembłowska; Ninela Irga-Jaworska; Wanda Badowska; Michał Dopierała; Paweł Kurzawa; Katarzyna Derwich
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

Review 8.  The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients.

Authors:  Justyna Derebas; Kinga Panuciak; Mikołaj Margas; Joanna Zawitkowska; Monika Lejman
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.